- 201. c-erbB-2
- [The ERBB2 gene encodes a putative tyrosine kinase growth factor receptor EGFR2, p185 HER2/NEU antigen, similar to the EGF receptor. The ERBB2, ERBB3, and ERBB4 genes encode heregulin/neuregulin receptors, members of the EGFR-related type I receptor tyrosine kinase subfamily. The encoded proteins form homo- and heterodimers, which complicates assignment of function: ERBB2 homodimers do not bind heregulin, but ERBB2/ERBB3 heterodimers do. Herstatin is a secreted alternative ERBB2 product, of the extracellular domain, that binds to p185ERBB2, disrupts ERBB2 dimers, reduces p185 phosphorylation, and inhibits growth. Human ERBB2 gene is located at 17p12-21. Overexpression of HER-2 correlates with poor prognosis in breast carcinoma. ( NCI )] (UMLS (NCI) C0069515) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 251. C1-C4 FX-CL/CORD INJ NEC
- [ ] (UMLS (ICD9CM) C0159564) =Injury or Poisoning
|
- 202. c-erbB-3
- [HER3/erbB3. Member of the EGF receptor (erbB) family. Receptor for NDF/heregulin (Neu differentiation factor); heterodimerizes with other type I receptor tyrosine kinases. It is overexpressed frequently in several common solid tumors, including in breast cancer. ( NCI )] (UMLS (NCI) C0072460) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 252. C1-C4 FX-CL/CORD INJ NOS
- [ ] (UMLS (ICD9CM) C0159560) =Injury or Poisoning
|
- 203. c-erbB-4
- [ErbB4 heterodimerizes with other type I receptor tyrosine kinases. In the peripheral nervous system, ErbB4 helps regulate glial proliferation and acts as a signaling molecule at the neuromuscular junction. In the mature CNS, ErbB4 is expressed in cerebellar granule cells and in a subset of cells that also express the neurotransmitter: aminobutyric acid. ErbB4 is critical in cardiac development. It is overexpressed frequently in several common solid tumors, including in breast cancer. ( NCI )] (UMLS (NCI) C0214098) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 253. C1-C4 FX-OP/ANT CORD SYN
- [ ] (UMLS (ICD9CM) C0159573) =Injury or Poisoning
|
- 204. c-erbB-5
- (UMLS (NCI) C1333354) ERBB5 Receptor Protein Tyrosine Kinase =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 254. C1-C4 FX-OP/CEN CORD SYN
- [ ] (UMLS (ICD9CM) C0159574) =Injury or Poisoning
|
- 205. c-Ets-1
- [A member of the ETS family of transcription factors, ETS1 Protein is a set of 42-52 kD nuclear phosphoproteins that activate transcription by interaction with purine-rich sequences in gene promoter/enhancer regions. (from OMIM 164720 and NCI) ( NCI )] (UMLS (NCI) C0107719) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 255. C1-C4 FX-OP/COM CORD LES
- [ ] (UMLS (ICD9CM) C0159572) =Injury or Poisoning
|
- 206. c-Ets-2
- [A member of the ETS family of transcription factors, ETS2 Protein activity is potentiated by signaling through the RAS-RAF-MEK kinase cascade and inhibited by direct interaction with the HLH ID1 protein. (from OMIM 164740 and NCI) ( NCI )] (UMLS (NCI) C0107720) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 256. C1-C4 FX-OP/CORD INJ NEC
- [ ] (UMLS (ICD9CM) C0159575) =Injury or Poisoning
|
- 207. C-FER
- [FER (FPS/FES related) protein is a tyrosine kinase expressed in lymphoid cells; phosphoprotein NCP94. Inhibition of CDH2 (the cytoplasmic domain) or of beta-1 integrin function results in release of FER from the cadherin complex and accumulation in the integrin complex, suggesting that FER may shuttle between cadherin and integrin complexes, perhaps mediating cross-talk between CDH2 and ITGB1. (from OMIM 176942 and NCI) ( NCI )] (UMLS (NCI) C0072450) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 257. C1-C4 FX-OP/CORD INJ NOS
- [ ] (UMLS (ICD9CM) C0159571) =Injury or Poisoning
|
- 208. c-FGR Protein
- [p55-FGR tyrosine kinase contains an SH2 domain, an SH3 domain and belongs to the SRC subfamily. (from OMIM 164940, Swiss-Prot P09769, and NCI) ( NCI )] (UMLS (NCI) C0072451) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 258. C10
- [A cell-surface enzyme found on prostate epithelial cells. It can inhibit cell migration of prostate cancer cells, probably by disrupting focal adhesion kinase phosphorylation. (from J Clin Invest 2000;106:1399-1407 via Medscape) ( NCI )] (UMLS (CSP) C0025250) =Enzyme =metalloendopeptidase;
|
- 209. c-fos Protein
- [nuclear, DNA binding protein; regulates transcription; product of the c-fos proto-oncogene. ( CSP )] (UMLS (NCI) C0596588) =Amino Acid, Peptide, or Protein; Biologically Active Substance =DNA binding protein;
| - 259. C10H12CaN2Na2O8
- [Contracted name for a salt of ethylenediaminetetraacetate, an agent used as a chelator of lead and some other heavy metals. C10H12CaN2Na2O8. ( NCI )] (UMLS (NCI) C0006692) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid ;
=EDETATE;
=EDETATE CALCIUM DISODIUM 0.05 MG/ML;
EDETATE CALCIUM DISODIUM 200 MG/ML;
|
- 210. C-Jun Kinase 2
- [Expressed as alpha-1, -2, beta-1, -2 isoforms by human MAPK9 Gene (MAPK Family), MAP Kinase 9 is a stress/cytokine-induced Ser/Thr kinase that acts as an integration point for multiple biochemical signals involved in target transcription factor regulation, such as c-Jun and ATF2. Alpha-1, and 2 bind c-Jun; beta-1 and 2 bind ATF2. JunB and JunD are not substrates for alpha-2. Inhibited by dual specificity phosphatases, and phosphothreonine/tyrosine activated by a Ras-dependent dual specificity MAP2K4/MAP2K7 cascade, MAPK9 mediates immediate-early gene expression. MAPK9 binds scaffolding proteins MAPK8IP1/2/3. MAPK9/UV-induced apoptosis appears related to cytochrome c-mediated cell death. Increased p53 stability in nonstressed cells results from MAPK9 blocked p53 ubiquitination. MAPK9 appears required for T-helper cell differentiation into Th1 cells. (NCI) ( NCI )] (UMLS (NCI) C1367019) C-Jun N-Terminal Kinase 2;
Jun Kinase;
MAP Kinase 9;
MAPK9;
Stress-Activated Protein Kinase JNK2 =Amino Acid, Peptide, or Protein; Enzyme | - 260. C11 isotope
- [ ] (UMLS (CSP) C0302944) =Element, Ion, or Isotope
|
- 211. c-Jun Kinase 3
- [The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This protein is a neuronal-specific form of c-Jun N-terminal kinases (JNKs). Through its phosphorylation and nuclear localization, this kinase plays regulatory roles in the signaling pathways during neuronal apoptosis. Beta-arrestin 2, a receptor-regulated MAP kinase scaffold protein, is found to interact with, and stimulate the phosphorylation of this kinase by MAP kinase kinase 4 (MKK4). Cyclin-dependent kianse 5 can phosphorylate, and inhibit the activity of this kinase, which may be important in preventing neuronal apoptosis. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. (LocusLink) ( NCI )] (UMLS (NCI) C1455843) C-Jun N-Terminal Kinase 3;
MAP Kinase 10;
MAP Kinase P49 3F12;
MAPK10;
Stress Activated Protein Kinase Beta;
Stress-Activated Protein Kinase JNK3 =Amino Acid, Peptide, or Protein; Enzyme | - 261. C13 isotope
- [ ] (UMLS (CSP) C0598053) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope
|
- 212. c-JUN N-Terminal Kinase
- [Encoded by Human MAPK8 Gene (MAPK Family) as alternative isoforms (alpha-1, -2, beta-1, -2), MAP Kinase 8 is a stress/cytokine-induced Ser/Thr kinase that acts as an integration point for multiple biochemical signals involved in target transcription factor regulation, such as c-Jun and ATF2. Beta-1 binds c-Jun; alpha-1, -2, and beta-2 bind c-Jun or ATF2. Inhibited by dual specificity phosphatases, and phosphothreonine/tyrosine activated by a Ras-dependent dual specificity MAP2K4/MAP2K7 cascade, MAPK8 mediates immediate-early gene expression. MAPK8 binds scaffolding proteins MAPK8IP1/2/3. MAPK8/UV-induced apoptosis appears related to cytochrome c-mediated cell death. MAPK8 activation by TNF-alpha induces apoptosis. MAPK8 appears to be required for T-helper cell differentiation into Th1 cells. (NCI) ( NCI )] (UMLS (NCI) C0380051) =Amino Acid, Peptide, or Protein; Enzyme
| - 262. C19 steroid
- [ ] (UMLS (CSP) C0599683) =Steroid ;
|
- 213. c-JUN Protein
- [Encoded by JUN Family Genes, nuclear leucine zipper JUN Family Proteins (JUN, JUNB, and JUND) can homodimerize, or heterodimerize with nuclear leucine zipper FOS Family Proteins, to form the specific promoter/enhancer DNA-binding AP-1 transcription factor complex that regulates target gene transcription in cell proliferation, differentiation, and transformation. (NCI) ( NCI )] (UMLS (NCI) C0085296) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 263. C21 steroid
- [saturated derivatives of the steroid pregnane. ( CSP )] (UMLS (CSP) C0033006) =Steroid =Steroid;
=adrenal cortex hormone;
pregnanolone;
17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione;
17-Hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate;
Pregnadienes;
Pregnenes |
- 214. c-K-Ras
- [p21 K-RAS protein is encoded by the K-RAS gene. Two KRAS isoforms are produced by alternative splicing. RAS proteins are involved in transmembrane signal transduction as monomeric GTP-binding proteins, with intrinsic GTPase activity, that alternate between an inactive GDP-bound form and an active GTP-bound form. RAS proteins are activated by a guanine nucleotide-exchange factor and inactivated by a GTPase-activating protein. Mitogen-stimulated RAS enhances MYC accumulation by stabilizing MYC protein. This stabilization is dependent on the RAS/RAF/MAPK pathway, which appears to inhibit the proteasome-dependent degradation of MYC. Mutations of specific amino acids activate c-RAS to transform cells and are implicated in a variety of human tumors. KRAS is involved in malignancy much more often than is HRAS. (from OMIM 190070, SWISS-PROT P01116, P01118, and NCI) ( NCI )] (UMLS (NCI) C0079973) =Amino Acid, Peptide, or Protein; Enzyme
| - 264. C21-Steroid Hormone Metabolism
- [The chemical reactions and pathways involving C21-steroid hormones, steroid compounds containing 21 carbons which function as hormones. [GOC:ai] ( GO )] (UMLS (NCI) C1158332) C21-Steroid Hormone Metabolism Pathway =Molecular Function
|
- 215. C-Kit Ligand
- [expressed during embryogenesis and provides key signal in multiple aspects of mast cell differentiation and function; hematopoietic growth factor and ligand of c-kit receptor CD117. ( CSP )] (UMLS (NCI) C0143630) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Cytokine;
hematopoietic growth factor | - 265. C21KG
- [Encoded by human RAP1A Gene (RAS GTPase Family), 184-aa 21-kDa (precursor) membrane-bound RAS-Related Protein RAP1A is activated by guanine nucleotide-exchange factors EPAC and EPAC2, in a cAMP-dependent manner, and by GFR. Interacting with RAS GAPs and RAF in a competitive manner, RAP1A counteracts RAS mitogenic function. (NCI) ( NCI )] (UMLS (NCI) C0967718) G-22K;
GTP-Binding Protein SMG-P21A;
KREV-1 Protein;
RAP1A;
RAP1A Member of RAS Oncogene Family;
RAS-Related Protein RAP1A;
SMGP21 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 216. C-Long
- (UMLS (NCI) C0699149) =Carbohydrate; Pharmacologic Substance; Vitamin
| - 266. C22orf19
- [Identified as a novel Fms-interacting protein. Overexpression in a bipotential myeloid progenitor cell line prevented M-CSF induced macrophage differentiation. Instead, cells differentiated into granulocytes. Thus, appears to have an effect on lineage commitment. (from Oncogene 1999;18:6488-95) ( NCI )] (UMLS (NCI) C1334876) Chromosome 22 Open Reading Frame 19 =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 217. C-LUC EXC MAX SINUS LES
- [ ] (UMLS (ICD9CM) C0189137) =Therapeutic or Preventive Procedure
| - 267. C2B8 Monoclonal Antibody
- [A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. ( NCI )] (UMLS (NCI) C0393022) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =[AN000] ANTINEOPLASTICS;
Unclassified Ingredients =RITUXIMAB 10 MG/ML;
|
- 218. C-MALT
- (UMLS (NCI) C1367653) Cutaneous Immunocytoma;
Marginal Zone B Cell Lymphoma of Skin;
Marginal Zone B Cell Lymphoma of the Skin;
Primary Cutaneous Marginal Zone B Cell Lymphoma of Mucosa-Associated Lymphoid Tissue;
Primary Cutaneous Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue;
SALT Lymphoma;
Skin-Associated Lymphoid Tissue Lymphoma =Neoplastic Process ;
| - 268. C3
- [Complement Component 3, encoded by the C3 gene plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. People with C3 deficiency are susceptible to bacteria infection. (From LocusLink) ( NCI )] (UMLS (NCI) C0009506) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 219. c-mer Proto-oncogene Tyrosine Kinase
- [Expressed in monocytes, bone marrow, and tissues of epithelial and reproductive origin by human MERTK Gene (AXL/UFO Family), 999-aa 110-kDa (precursor) Receptor Tyrosine Kinase MERTK contains 2 extracellular N-terminal Ig-like C2-type domains and 2 membrane proximal fibronectin type III domains, a putative transmembrane segment, a tyrosine kinase KWIAIES domain, several N-glycosylation sites, and tyrosine phosphorylation sites. Not expressed in normal B- and T-lymphocytes, MERTK is expressed in numerous neoplastic B-and T-cell lines. MERTK defects cause retinitis pigmentosa. (NCI) ( NCI )] (UMLS (NCI) C1259418) EC 2.7.1.112;
MERTK;
Receptor Tyrosine Kinase MerTK =Amino Acid, Peptide, or Protein; Enzyme; Receptor | - 269. C3
- [This gene plays a regulatory role in the complement pathway, which is comprised of a complex proteolytic cascade. ( NCI )] (UMLS (NCI) C1332656) C3 Gene;
Complement Component 3 Gene =Gene or Genome ;
|
- 220. C-MER Proto-Oncogene Tyrosine Kinase Gene
- [This gene plays a role in tissue homeostasis and mutations in the gene are associated with the onset of autosomal recessive retinitis pigmentosa. ( NCI )] (UMLS (NCI) C1364081) MERTK;
MERTK Gene =Gene or Genome | - 270. C3 Deficiency
- (UMLS (NCI) C1332655) =Disease or Syndrome ;
|
- 221. C-MET
- [The MET proto-oncogene encodes hepatocyte growth factor receptor, a cell surface receptor-like tyrosine kinase comprised of disulfide-linked 50 kD (alpha) and 145 kD (beta) subunits. In the fully processed c-MET product, the alpha subunit is extracellular, and the beta subunit has extracellular, transmembrane, and tyrosine kinase domains, as well as sites of tyrosine phosphorylation. The beta subunit of the c-MET proto-oncogene product is the cell surface receptor for hepatocyte growth factor. c-MET is related to the insulin receptor and ABL oncogene. (from OMIM 164860 and NCI) ( NCI )] (UMLS (NCI) C1456828) Hepatocyte Growth Factor Receptor;
HGFR;
HGF-SF Receptor;
MET Gene Product =Amino Acid, Peptide, or Protein; Receptor | - 271. C3 Vertebra
- (UMLS (NCI) C0459939) =Body Part, Organ, or Organ Component ;
|
- 222. c-Met-related Tyrosine Kinase
- [A member of the MET receptor family. The protein is membrane-spanning disulfide-linked heterodimer with intracellular tyrosine kinase activity. It is synthesized as a single polypeptide which is processed to the 185-kD heterodimer of 35-kD (alpha) and 150-kD (beta) subunits joined by the predicted disulfide linkage. The protein is a specific cell surface receptor for macrophage stimulating protein. Targeted expression in mice results in frequent, multiple lung tumors. It may also play a role in progression of some colorectal cancers (from OMIM, Oncogene 2002;21:6382-6 and Oncogene 2003;22:186-97) ( NCI )] (UMLS (NCI) C0215510) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 272. C3H
- (UMLS (NCI) C0025920) =Mammal ;
|
- 223. C-MOPP
- [A derivative of the original MOPP regimen consisting of cyclophosphamide, vincristine, procarbazine and prednisone used as an initial treatment for Hodgkin's lymphoma. Also used for the treatment of non-Hodgkin's lymphoma. ( NCI )] (UMLS (NCI) C0110666) =Therapeutic or Preventive Procedure
| - 273. C4 Vertebra
- (UMLS (NCI) C0459941) =Body Part, Organ, or Organ Component ;
|
- 224. C-MOS
- [Cellular proteins encoded by the c-mos genes (GENES, MOS). They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time. ( NCI )] (UMLS (NCI) C0072454) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 274. C5
- [Encoded by human C5 Gene, Complement Component 5 is a precursor protein containing 1 anaphylatoxin-like domain and 1 NTR domain and similar to C3, C4, and Alpha-2-Macroglobulin. By removal of 4 basic residues, C5 is processed to disulfide linked alpha and beta chains. C5 convertase cleaves the alpha chain, releasing C5a anaphylatoxin and generating C5b. C5 convertase activation of C5 initiates assembly of C5-C9 late complement components into a membrane attack complex; C5b-C6 complex is the assembly foundation of the lytic complex. C5a stimulates chemokinesis and chemotaxis of polymorphonuclear leukocytes to inflammation sites. C5 anaphylatoxin mediates local inflammatory processes; smooth muscle contraction, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. (NCI) ( NCI )] (UMLS (NCI) C0009519) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 225. C-MPL Ligand
- [A colony-stimulating factor that stimulates the production of blood cells, especially platelets, during chemotherapy. It is a cytokine that belongs to the family of drugs called hematopoietic (blood forming) agents. ( NCI )] (UMLS (NCI) C0040052) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 275. C5
- [Human C5 wild-type allele is located within 9q33-q34 and is approximately 98 kb in length. This allele, which encodes complement C5 protein, is involved in the complement system, inflammatory responses, and histamine release. ( NCI )] (UMLS (NCI) C1367710) C5 Gene;
Complement Component 5 Gene =Gene or Genome ;
|
- 226. C-MPL Ligand
- (UMLS (NCI) C0392939) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 276. C5 Deficiency
- (UMLS (NCI) C1332657) =Disease or Syndrome ;
|
- 227. c-Myb
- [Encoded by human MYB Gene as 6 alternative isoforms, 640 aa 72-kDa nuclear c-MYB protein is a DNA-binding transcriptional activator critical for hematopoietic progenitor cell proliferation and differentiation. MYB contains 3 N-terminal MYB-like DNA-binding domains that specifically recognize YAAC[GT]G, a central transcriptional activation domain and a C-terminal transcriptional repression domain. MYB may interact with HIPK2 and NLK; phosphorylation by NLK on multiple sites may induce proteasomal degradation. Ubiquitination may be mediated by SIAH1. ( NCI )] (UMLS (NCI) C0072473) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 277. C5 Vertebra
- (UMLS (NCI) C0459943) =Body Part, Organ, or Organ Component ;
|
- 228. c-Myb LR-3001
- (UMLS (NCI) C0253788) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 278. C5-C7 FX-CL/ANT CORD SYN
- [ ] (UMLS (ICD9CM) C0159567) =Injury or Poisoning
|
- 229. c-MYC Protein
- [Product of the c-myc proto-oncogene. A nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. ( NCI )] (UMLS (NCI) C0080065) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 279. C5-C7 FX-CL/CEN CORD SYN
- [ ] (UMLS (ICD9CM) C0159568) =Injury or Poisoning
|
- 230. c-Raf
- [A serine/threonine kinase involved in cellular signal transduction. Raf is a component of a signal transduction pathway leading to increased gene expression through the c-Jun DNA binding site. ( NCI )] (UMLS (NCI) C0139905) =Amino Acid, Peptide, or Protein; Enzyme
| - 280. C5-C7 FX-CL/COM CORD LES
- [ ] (UMLS (ICD9CM) C0159566) =Injury or Poisoning
|
- 231. C-Reactive Protein, Pentraxin-Related Gene
- [This gene plays a role in immune and inflammatory processes. ( NCI )] (UMLS (NCI) C1413716) CRP;
CRP Gene =Gene or Genome | - 281. C5-C7 FX-CL/CORD INJ NEC
- [ ] (UMLS (ICD9CM) C0159569) =Injury or Poisoning
|
- 232. c-Ros Tyrosine Kinase
- [A type I membrane protein, c-ROS tyrosine kinase is probably a cell growth- or differentiation factor receptor that belongs to the insulin receptor family, sevenless subfamily. (from Swiss-Prot P08922 and NCI) ( NCI )] (UMLS (NCI) C0216760) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 282. C5-C7 FX-CL/CORD INJ NOS
- [ ] (UMLS (ICD9CM) C0159565) =Injury or Poisoning
|
- 233. c-yes Kinase
- [p61-YES is associated with tyrosine-specific protein kinase activity, shows a high degree of homology with SRC, and contains one SH2 domain and one SH3 domain. (from OMIM 164880, Swiss-Prot P07947, and NCI) ( NCI )] (UMLS (NCI) C0919493) p61-YES;
YES1;
YES1 Protein Tyrosine Kinase =Amino Acid, Peptide, or Protein; Enzyme | - 283. C5-C7 FX-OP/ANT CORD SYN
- [ ] (UMLS (ICD9CM) C0159578) =Injury or Poisoning
|
- 234. C.A.T. SCAN OF ABDOMEN
- [ ] (UMLS (ICD9CM) C0412620) =Diagnostic Procedure
| - 284. C5-C7 FX-OP/CEN CORD SYN
- [ ] (UMLS (ICD9CM) C0159579) =Injury or Poisoning
|
- 235. C.A.T. SCAN OF HEAD
- (UMLS (ICD9CM) C0202691) =Diagnostic Procedure
| - 285. C5-C7 FX-OP/COM CORD LES
- [ ] (UMLS (ICD9CM) C0159577) =Injury or Poisoning
|
- 236. C.A.T. SCAN OF KIDNEY
- [ ] (UMLS (ICD9CM) C0412623) =Diagnostic Procedure
| - 286. C5-C7 FX-OP/CORD INJ NEC
- [ ] (UMLS (ICD9CM) C0159580) =Injury or Poisoning
|
- 237. C.A.T. SCAN OF THORAX
- [ ] (UMLS (ICD9CM) C0202823) =Diagnostic Procedure
| - 287. C5-C7 FX-OP/CORD INJ NOS
- [ ] (UMLS (ICD9CM) C0159576) =Injury or Poisoning
|
- 238. C.Difficile Colitis
- (UMLS (NCI) C0238106) =Disease or Syndrome ;
| - 288. C57BL
- (UMLS (NCI) C0025921) =Mammal ;
|
- 239. C.I. Basic Red 9
- (UMLS (NCI) C0282796) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
| - 289. C5a
- [Smaller fragment formed when C5 convertase splits C5 into C5a and C5b. C5a is a 74-amino acid peptide that includes a carboxy-terminal arginine crucial for its spasmogenic activity and a carbohydrate moiety. Initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5a is the most potent anaphylatoxin, mediating immediate hypersensitivity. C5a is also chemotactic for neutrophils and monocytes. ( NCI )] (UMLS (NCI) C0009521) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 240. C.I. Pigment White 4
- [A compound that may enhance immune function, especially when administered by inhalation. ( NCI )] (UMLS (NCI) C0043491) =Pharmacologic Substance; Inorganic Chemical ;
=oxide;
[TN405] ZINC;
Zinc Compounds;
[PH000] PHARMACEUTICAL AIDS / REAGENTS;
[DE900] DERMATOLOGICALS, TOPICAL OTHER;
Unclassified Ingredient Preparations =ZINC OXIDE EMULSION;
ZINC (AS OXIDE) 25 MG;
ZINC (AS OXIDE) 5 MG;
TING PWDR,TOP;
BENZOCAINE/PHENOL/VITAMIN E/ZINC OXIDE OINT,TOP;
BISCOLAN SUPP,RTL;
BISMUTH SUBGALLATE/BORIC ACID/ZINC OXIDE SUPP,RTL;
CARRINGTON MOISTURE BARRIER/ZINC CREAM,TOP;
CINOXATE/ZINC OXIDE CREAM,TOP; More… | - 290. C6 Beta-Chemokine
- [Expressed in lung, liver, skeletal muscle, bone marrow, placenta, pancreas, and fetal liver by human CCL23 Gene (Intercrine Beta Family), secreted immunoregulatory Small Inducible Cytokine A23 Isoform Ckbeta8 is a potent CCR1 receptor agonist and suppressor of progenitor cell colony formation with chemotactic activity for resting T lymphocytes, monocytes, and neutrophils in inflammatory processes. ( NCI )] (UMLS (NCI) C0538072) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 241. C.Sordelli Colitis
- (UMLS (NCI) C0858151) =Disease or Syndrome
| - 291. C6 Vertebra
- (UMLS (NCI) C0459944) =Body Part, Organ, or Organ Component ;
|
- 242. C/EBP
- [A protein which binds to enhancers having a conserved CCAAT sequence. ( NCI )] (UMLS (NCI) C0108685) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 292. C6H12CLN3O4S
- [A chloroethylating nitrosourea that causes DNA cross-linking, inhibiting DNA replication. (NCI) ( NCI )] (UMLS (NCI) C0067099) =Organic Chemical; Pharmacologic Substance ;
|
- 243. C/EBP Epsilon
- [C/EBP epsilon is a CCAAT enhancer-binding protein and bZIP transcription factor uniquely expressed in, and essential for differentiation of, granulocytic progenitor cells. C/EBP epsilon forms homo- or heterodimers with other family members and expression is enhanced by retinoids. Four isoforms are expressed from different promoters and an alternate start codon. (from OMIM 600749 and NCI) ( NCI )] (UMLS (NCI) C1384540) CCAAT/Enhancer Binding Protein Epsilon;
CEBPE;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 293. C6orf49
- [This gene plays a role in cancer differentiation. ( NCI )] (UMLS (NCI) C1332658) C6orf49 Gene;
Chromosome 6 Open Reading Frame 49 Gene =Gene or Genome ;
|
- 244. C01, C02, C03, C04, C05, C06, C07, C08
- (UMLS (HL7) C1548708) =Intellectual Product =Message structure;
| - 294. C6orf49
- [Encoded by human OBTP Gene, 74-amino acid 8 kD Over-Expressed Breast Tumor Protein contains two LIM domains and may mediate protein-protein interactions. (from SWISS-PROT, and NCI) ( NCI )] (UMLS (NCI) C1335080) OBTP Protein;
Over-Expressed Breast Tumor Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 245. C06 grant
- [ ] (UMLS (CSP) C1536998) =Governmental or Regulatory Activity
| - 295. C7 Vertebra
- (UMLS (NCI) C0223176) =Body Part, Organ, or Organ Component
|
- 246. C09, C10, C11, C12
- (UMLS (HL7) C1548709) =Intellectual Product =Message structure;
| - 296. C9orf19
- [This gene plays a role in the immune response. ( NCI )] (UMLS (NCI) C1425234) C9orf19 Gene;
Chromosome 9 Open Reading Frame 19 Gene =Gene or Genome |
- 247. C1 inhibitor deficiency
- [recurring attacks of transient edema suddenly appearing in areas of the skin or mucous membranes and occasionally of the viscera, often associated with dermatographism, urticaria, erythema, and purpura. ( CSP )] (UMLS (CSP) C0019243) =Disease or Syndrome ;
=blood vessel disorder;
enzyme deficiency;
complement deficiency;
| - 297. CA
- [A state on the western coast of the United States. Its capital is Sacramento. ( NCI )] (UMLS (NCI) C0006754) =Geographic Area ;
◊ [North American country north of the United States of America; capital city is Ottawa. ( CSP )] (UMLS (NCI) C0006823) Geographic Area ; North America; RealmOfUse ◊ [A term for diseases in which abnormal cells divide without control. Cancer cells can invade nearby tissues and can spread through the bloodstream and lymphatic system to other parts of the body. ( NCI )] (UMLS (NCI) C0006826) Neoplastic Process ; Disease; multiple primary neoplasia; environment related neoplasm/cancer; Detectable Residual Disease; Childhood Cancer; preneoplastic state; host neoplasm interaction; psychological aspect of cancer; neoplasm/cancer site; neoplasm/cancer type; AIDS related neoplasm; hormone related cancer |
- 248. C1-C4 FX-CL/ANT CORD SYN
- [ ] (UMLS (ICD9CM) C0159562) =Injury or Poisoning
| - 298. CA
- [A quantitative measurement of the amount of calcium present in a sample. ( NCI )] (UMLS (NCI) C0201925) =Laboratory Procedure
|
- 249. C1-C4 FX-CL/CEN CORD SYN
- [ ] (UMLS (ICD9CM) C0159563) =Injury or Poisoning
| - 299. CA 125
- [A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and that may suggest the presence of some types of cancer. ( NCI )] (UMLS (NCI) C0006610) =Carbohydrate; Immunologic Factor ;
|
- 250. C1-C4 FX-CL/COM CORD LES
- [ ] (UMLS (ICD9CM) C0159561) =Injury or Poisoning
| - 300. CA IN SITU BOWEL NEC/NOS
- (UMLS (ICD9CM) C0154065) =Neoplastic Process
|
home
